‘Dipstick Test’ for rapid diagnosis of Plasmodium falciparum is based on
**Core Concept**
The 'Dipstick Test' for rapid diagnosis of Plasmodium falciparum is a point-of-care test that utilizes immunochromatographic technology to detect specific antigens or antibodies associated with the parasite. This test is crucial for early detection and management of malaria, especially in resource-limited settings.
**Why the Correct Answer is Right**
The correct answer is **HRP2 (Histidine-Rich Protein 2)**. The HRP2-based dipstick test detects the presence of HRP2 antigen in the patient's blood, which is a specific protein produced by P. falciparum parasites. This protein is released into the bloodstream in large quantities during the parasite's life cycle, making it an ideal target for antigen-based detection. The test works by using antibodies that specifically bind to the HRP2 antigen, resulting in a visible line or band on the test strip.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because HRP2 is a specific antigen associated with P. falciparum, whereas lactate dehydrogenase (LDH) is a more general antigen found in various Plasmodium species.
* **Option B:** This option is incorrect because the 'Dipstick Test' is not based on detection of the parasite's DNA, but rather on the presence of specific antigens or antibodies.
* **Option C:** This option is incorrect because the 'Dipstick Test' is not based on detection of the parasite's proteins, but rather on specific antigens or antibodies.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the HRP2-based dipstick test may produce false-positive results in patients who have been treated with artemisinin-based combination therapies (ACTs), as these treatments can cause the parasite to release HRP2 antigen into the bloodstream. Therefore, a negative result on the HRP2-based dipstick test may not always rule out P. falciparum infection.
**Correct Answer:** D. HRP2 (Histidine-Rich Protein 2)